TAS-303 effects on urethral sphincter function in women with stress urinary incontinence: phase I study

INTRODUCTION AND HYPOTHESIS: TAS-303, which selectively inhibits noradrenaline reuptake, was developed for treating stress urinary incontinence (SUI). The proximal urethra mainly comprises smooth muscle fibers in which α1 adrenergic receptors are abundant. This study was conducted to evaluate the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Yono, Makoto, Irie, Shin, Gotoh, Momokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902327/
https://www.ncbi.nlm.nih.gov/pubmed/32747975
http://dx.doi.org/10.1007/s00192-020-04470-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902327/
https://www.ncbi.nlm.nih.gov/pubmed/32747975
http://dx.doi.org/10.1007/s00192-020-04470-7

Ejemplares similares